Comparison of total body irradiation versus non-total body irradiation containing regimens for de novo acute myeloid leukemia in children
Open Access
- 18 June 2020
- journal article
- research article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 106 (7), 1839-1845
- https://doi.org/10.3324/haematol.2020.249458
Abstract
With limited data comparing hematopoietic cell transplant outcomes between myeloablative total body irradiation (TBI) containing and non-TBI regimens in children with de novo acute myeloid leukemia, the aim of this study was to compare transplant-outcomes between these regimens. Cox regression models were used to compare transplant-outcomes after TBI and non-TBI regimens in 624 children transplanted between 2008 and 2016. Thirty two percent (n=199) received TBI regimens whereas 68% (n=425) received non-TBI regimens. Five-year non-relapse mortality was higher with TBI regimens (22% vs. 11%, p<0.0001) but relapse was lower (23% vs. 37%, p<0.0001) compared to non-TBI regimens. Consequently, overall (62% vs. 60%, p=1.00) and leukemia-free survival (55% vs. 52%, p=0.42) did not differ between treatment groups. Grade II-IV acute GVHD was higher with TBI regimens (56% vs. 27%, p<0.0001) but not chronic GVHD. The 3-year incidence of gonadal or growth hormone deficiency was higher with TBI regimens (24% vs. 8%, p<0.001) but there were no differences in late pulmonary, cardiac or renal impairment. In the absence of a survival advantage, the choice of TBI or non-TBI regimen merits careful consideration with the data favoring non-TBI regimens to limit the burden of morbidity associated with endocrine dysfunction.This publication has 31 references indexed in Scilit:
- Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBIBlood, 2013
- Risk Factors Associated with Liver Injury and Impact of Liver Injury on Transplantation-Related Mortality in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2013
- How I treat pediatric acute myeloid leukemiaBlood, 2012
- NCI, NHLBI First International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Etiology and Pathogenesis of Late Effects after HCT Performed in Childhood—Methodologic ChallengesTransplantation and Cellular Therapy, 2011
- SAS macros for estimation of direct adjusted cumulative incidence curves under proportional subdistribution hazards modelsComputer Methods and Programs in Biomedicine, 2011
- Pharmacokinetic targeting of intravenous busulfan reduces conditioning regimen related toxicity following allogeneic hematopoietic cell transplantation for acute myelogenous leukemiaJournal of Hematology & Oncology, 2010
- Influence of chemotherapy courses on the rate of bloodstream infections during neutropenia in adult acute myeloid leukaemiaScandinavian Journal of Infectious Diseases, 2008
- A SAS macro for estimation of direct adjusted survival curves based on a stratified Cox regression modelComputer Methods and Programs in Biomedicine, 2007
- Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplantInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Score test of homogeneity for survival dataLifetime Data Analysis, 1995